Daily News Podcast

FDA approves Zephyr valves for emphysema


 

The Food and Drug Administration has approved the Zypher endobronchial valve system for patients with severs emphysema who are experiencing difficulty breathing. Also today, meth use is climbing alongside the opioid epidemic, pain remains after rheumatoid arthritis diagnosis, and higher RA biologic drug levels linked with more infections. Subscribe to the MDedge Daily News for today’s top news.

Recommended Reading

JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Internal Medicine
Patients going without as insulin prices skyrocket
MDedge Internal Medicine
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Internal Medicine
Opioids do more harm than good for musculoskeletal pain
MDedge Internal Medicine
Adalimumab strikes out for aortic inflammation in psoriasis
MDedge Internal Medicine
Addiction: Veterans with pain, opioid use disorder
MDedge Internal Medicine
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Internal Medicine
Medicare beneficiaries are dying differently
MDedge Internal Medicine
Updated anthrax vaccine recommendations
MDedge Internal Medicine
Diabetes risk may rise with work hours
MDedge Internal Medicine